Clinical trial
Open-label Multi-cohort Study of the Tolerability, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers After a Single Intravenous Injection in Increasing Doses
NCT06475404 is registered in ClinicalTrials.gov with AO GENERIUM as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-label Multi-cohort Study of the Tolerability, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers After a Single Intravenous Injection in Increasing Doses
- Lead sponsor
- AO GENERIUM
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 6, 2023
- Completion date
- September 20, 2023
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metabolic diseases, mucopolysaccharidosis type ii